FibroGen, Inc. (NASDAQ:FGEN) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to FibroGen First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Fibrogen Inc (FGEN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 340,000 | $2,634,150 | +25% | 0.04% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 88,502.44 | $685,893 | +75% | 0% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 27,048.24 | $209,556 | -24% | 0% |
| 4. | Renaissance Technologies Jim Simons | 19,250.6 | $149,144 | -65% | 0% |
| 5. | Millennium Management Israel Englander | 17,675.2 | $136,939 | -47% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.35 | 145,000 | $50,663.00 | 543,329 | 2025-03-24 | Filing | |
| $0.34 | 50,000 | $17,040.00 | 373,722 | 2025-03-21 | Filing | |
| $0.35 | 250,000 | $88,000.00 | 323,722 | 2025-03-20 | Filing | |
| $1.17 | 22,123 | $25,883.91 | 82,123 | 2024-06-12 | Filing | |
| $1.91 | 50,000 | $95,470.00 | 470,178 | 2024-03-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.03 | 2,000 | $2,060.00 | 28,866 | 2023-09-01 | Filing | |
| $1.91 | 2,000 | $3,820.00 | 30,866 | 2023-08-04 | Filing | |
| $2.69 | 2,000 | $5,380.00 | 32,866 | 2023-07-11 | Filing | |
| $2.80 | 1,880 | $5,264.00 | 374,722 | 2023-07-07 | Filing | |
| $16.53 | 791 | $13,074.99 | 108,261 | 2023-06-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 234,365 | $1,816,329 | 0% | |
| 2. | 149,632.8 | $1,159,282 | 0% | |
| 3. | 94,893.52 | $735,189 | 0% | |
| 4. | 43,179.84 | $334,625 | 0% | |
| 5. | 23,378.04 | $181,121 | 0% |
News See All
FibroGen, Inc. (NASDAQ:FGEN) Q4 2024 Earnings Call Transcript
Operator: Hello everyone, and welcome to the FibroGen Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
FibroGen, Inc. (NASDAQ:FGEN) Q3 2024 Earnings Call Transcript
Operator: Good day and welcome to the FibroGen Third Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode.
FibroGen, Inc. (NASDAQ:FGEN) Q2 2024 Earnings Call Transcript
Operator: Good day and welcome to the FibroGen Second Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript
FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.33272 EPS, expectations were $-0.31.
FibroGen, Inc. (NASDAQ:FGEN) Q4 2023 Earnings Call Transcript
FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.57 EPS, expectations were $-0.42. FibroGen, Inc.
FibroGen, Inc. (NASDAQ:FGEN) Q3 2023 Earnings Call Transcript
Operator: Hello and welcome to the FibroGen's Third Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.
FibroGen, Inc. (NASDAQ:FGEN) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the FibroGen's Second Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.
FibroGen, Inc. (NASDAQ:FGEN) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to FibroGen's First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.